ProteinQure Closes $11M in Series A Financing

| Posted on |

Here’s a structured summary based on the provided information about ProteinQure:

Company Information

  • Startup: ProteinQure
  • Website: proteinqure.com
  • Location: Toronto, Canada
  • Industry: Biotechnology (Developing computational peptide therapeutics)
  • CEO: Lucas Siow

Fundraising Details

  • Total Raised: $16M (including previous funding)
  • Recent Fundraise:
    • Funding Amount: $11M
    • Series: Series A
    • Date: Not specified in the text

Investors

  • Lead Investor: Tom Williams, Heron Rock Fund
  • Additional Investors:
    • Golden Ventures
    • Kensington Capital
    • Others (not specified)

Purpose of Funding

  • To support the initiation of the first clinical trial for PQ203, a first-in-class peptide-drug conjugate for triple-negative breast cancer (TNBC).
  • Advancement of additional pipeline programs in neurology and nephrology.

Technology

  • Platform: ProteinStudio
  • Focus: Integrates machine learning, structural biology, and atomic-level simulations to design therapeutic peptides using non-natural amino acids for improved delivery and efficacy in targeted therapies.

This summary provides a concise overview of the key elements related to ProteinQure’s recent fundraising and business focus.

Source link

2025-05-28 14:47:31